EP2203432A4 - Procédé de traitement - Google Patents

Procédé de traitement

Info

Publication number
EP2203432A4
EP2203432A4 EP08831660A EP08831660A EP2203432A4 EP 2203432 A4 EP2203432 A4 EP 2203432A4 EP 08831660 A EP08831660 A EP 08831660A EP 08831660 A EP08831660 A EP 08831660A EP 2203432 A4 EP2203432 A4 EP 2203432A4
Authority
EP
European Patent Office
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08831660A
Other languages
German (de)
English (en)
Other versions
EP2203432A1 (fr
Inventor
Thomas B Leonard
Henry M Sarau
Aili L Lazaar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC filed Critical GlaxoSmithKline LLC
Publication of EP2203432A1 publication Critical patent/EP2203432A1/fr
Publication of EP2203432A4 publication Critical patent/EP2203432A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP08831660A 2007-09-21 2008-09-16 Procédé de traitement Withdrawn EP2203432A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97417507P 2007-09-21 2007-09-21
PCT/US2008/076519 WO2009039091A1 (fr) 2007-09-21 2008-09-16 Procédé de traitement

Publications (2)

Publication Number Publication Date
EP2203432A1 EP2203432A1 (fr) 2010-07-07
EP2203432A4 true EP2203432A4 (fr) 2011-04-27

Family

ID=40468285

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08831660A Withdrawn EP2203432A4 (fr) 2007-09-21 2008-09-16 Procédé de traitement

Country Status (2)

Country Link
EP (1) EP2203432A4 (fr)
WO (1) WO2009039091A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109152780B (zh) 2016-03-11 2021-10-01 阿迪亚生命科学公司 用于治疗结晶性关节病症的cxcr-2抑制剂

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039775A2 (fr) * 2002-10-29 2004-05-13 Smithkline Beecham Corporation Antagonistes du recepteur il-8
DE102005023834A1 (de) * 2004-11-20 2006-05-24 Bayer Healthcare Ag Substituierte[(Phenylethanoyl)amino]benzamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY25842A1 (es) * 1998-12-16 2001-04-30 Smithkline Beecham Corp Antagonistas de receptores de il-8
WO2001076530A2 (fr) * 2000-04-07 2001-10-18 Smithkline Beecham Corporation Antagonistes vis-a-vis du recepteur de l'interleukine-8 (il-8)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039775A2 (fr) * 2002-10-29 2004-05-13 Smithkline Beecham Corporation Antagonistes du recepteur il-8
DE102005023834A1 (de) * 2004-11-20 2006-05-24 Bayer Healthcare Ag Substituierte[(Phenylethanoyl)amino]benzamide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EIDELMAN O ET AL: "Cystic fibrosis and the use of pharmacogenomics to determine surrogate endpoints for drug discovery", AMERICAN JOURNAL OF PHARMACOGENOMICS, WOLTERS KLUWER HEALTH, XX, vol. 1, no. 3, 1 January 2001 (2001-01-01), pages 223 - 240, XP009146190, ISSN: 1175-2203 *
See also references of WO2009039091A1 *

Also Published As

Publication number Publication date
WO2009039091A1 (fr) 2009-03-26
EP2203432A1 (fr) 2010-07-07

Similar Documents

Publication Publication Date Title
EP2032131A4 (fr) Procédé de traitement
IL208354A0 (en) Methods of treatment
IL212348A0 (en) Treatment method
EP2129369A4 (fr) Traitement du thada
ZA200901364B (en) Method of treatment of photodermatoses
GB0711697D0 (en) Method of manufacture
IL217492A0 (en) Treatment method
ZA200907349B (en) Method of treating hair
SG2014009807A (en) Method for treatment of diseases
GB0718684D0 (en) Treatment method
PL2190451T3 (pl) Leczenie miażdżycy
VN25747A1 (en) Method of water treatment
GB0610746D0 (en) Method of treatment
EP2144886A4 (fr) Méthode de traitement du mélanome
EP2164494A4 (fr) Procédés de traitement
IL202002A0 (en) Method of treating diabetes
EP2194793A4 (fr) Procede de traitement de fruits et legumes frais
GB0723100D0 (en) Treatment of HFnEF
EP2424539A4 (fr) Procédé de traitement d&#39;une dépression
GB0717337D0 (en) Method of treatment
GB0700969D0 (en) Methods of treatment
GB0823435D0 (en) Method of treatment
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
GB0618227D0 (en) Novel method of treatment
GB0711228D0 (en) Treatment method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100421

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20110329

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111026